Copyright
©The Author(s) 2019.
World J Gastrointest Endosc. Mar 16, 2019; 11(3): 231-238
Published online Mar 16, 2019. doi: 10.4253/wjge.v11.i3.231
Published online Mar 16, 2019. doi: 10.4253/wjge.v11.i3.231
Table 2 Comparison of endoscopic retrograde cholangiopancreatography -related procedures between the positive group and the negative group
P group (n = 76) | N group (n = 19) | P value | |
Number of ERCP sessions (1/2) | 72/4 | 15/4 | 0.048 |
EST | 74 (97.4) | 17 (89.5) | 0.177 |
Diagnosability of bile or brush or ENBD cytology | 16/681 (23.5) | 5/19 (26.3) | 0.77 |
Cup diameter of biopsy forceps (1 mm/2 mm) | 8/68 | 2/17 | 1.0 |
Total number of biopsies | 2 (1 - 6) | 2 (1 - 7) | 0.039 |
Number of biopsies before biliary stenting | 2 (1 - 4) | 2 (1 - 3) | 0.119 |
Number of biopsies after biliary stenting | 2 (1 - 4) | 1 (1 - 6) | 0.065 |
PEP | 4 (5.3) | 0 (0) | 0.58 |
Moderate | 2 | ||
Severe | 2 |
- Citation: Takagi T, Sugimoto M, Suzuki R, Konno N, Asama H, Sato Y, Irie H, Watanabe K, Nakamura J, Kikuchi H, Takasumi M, Hashimoto M, Hikichi T, Ohira H. Appropriate number of biliary biopsies and endoscopic retrograde cholangiopancreatography sessions for diagnosing biliary tract cancer. World J Gastrointest Endosc 2019; 11(3): 231-238
- URL: https://www.wjgnet.com/1948-5190/full/v11/i3/231.htm
- DOI: https://dx.doi.org/10.4253/wjge.v11.i3.231